ADM Tronics Unlimited, Inc.
0.0900+0.01 (+12.5%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCQB · ADMT · USD
Key Stats
Market Cap
6.08MP/E (TTM)
-Basic EPS (TTM)
0.00Dividend Yield
0%Recent Filings
10-Q
Q1 FY2026 results
ADM Tronics posted solid Q1 FY2026 results, with net revenues climbing 13.5% y/y to $973,675, fueled by a 25% surge in electronics to $514,682, though chemicals dipped amid higher costs. Gross profit fell 7.6% y/y to $481,293 (49.4% margin, down from 60.7%), while operating income dropped 33.5% y/y to $109,234 as expenses rose 4.3%. Yet a hefty $225,750 unrealized investment gain propelled net income up 20.4% y/y to $327,634, equating to $0.00 diluted EPS on 67,588,492 shares. Cash dipped q/q to $369,790, with operating cash use narrowing to $(14,800) from $(59,146) y/y; free cash flow not disclosed in the 10-Q. Line of credit stands at $379,678 (8.87% rate, matures May 2026). One customer drove 41% of revenue. Customer concentration remains a key risk.
10-K
FY2025 results
ADM Tronics posted FY2025 revenue of $3.2 million, up 8% year-over-year, with engineering services surging 66% to $584,167 while chemicals dipped slightly; electronics held steady at $1.5 million. Gross profit climbed to $1.4 million from $1.1 million, fueled by higher volumes, yet operating loss narrowed to just $94,024 after slashing SG&A expenses by 28% and R&D by 10%. Q4 momentum showed in positive operating cash flow of nearly $10,000 for the year, reversing prior deficits, with backlog at $956,000 signaling steady demand. Liquidity sits tight at $383,000 cash plus $23,000 revolver availability, no dividends or buybacks noted. No annual guidance disclosed. Supply chain shortages persist as a key risk, delaying production and squeezing margins.
10-Q
Q3 FY2025 results
ADM Tronics posted Q3 FY2025 revenue of $749.5K, up 7.6% y/y from $696.5K, yet gross profit dipped to $268.2K (36% margin) from $321.4K (46%), driven by higher costs in chemicals and electronics while engineering surged 102% y/y. For the nine months, revenue climbed 10.6% y/y to $2.45M with gross profit jumping 42% to $1.21M (49% margin), flipping operations to a $29.2K gain from a $470.8K loss, though net loss widened to $18.2K from investment hits. Cash fell to $430.7K amid $510.9K operating outflow, offset by $338.5K investing inflow; line of credit stands at $380.2K with $19.8K availability at 8.87%. No non-GAAP metrics disclosed in the 10-Q. Customer concentration persists.
10-Q
Q2 FY2025 results
ADM Tronics posted solid Q2 revenue growth to $840K, up 11% y/y from $754K, driven by engineering services surging 153% while electronics dipped 12%; gross margins leaped to 50% from 27%, thanks to 23% lower costs. YTD through September 30, 2024, revenues hit $1.7M, up 12% y/y, flipping to $118K operating income from a $365K loss, with net income of $219K or $0.00 per diluted share on 67.6M shares. Engineering fueled the momentum, comprising 19% of Q2 sales, while foreign chemical sales added 11%. Cash sits at $428K, down from $537K at fiscal year-end, with operating cash use of $438K offset by $339K from investments; the $382K line of credit at 8.87% leaves $18K available, no covenants noted. No M&A or non-GAAP metrics disclosed in the 10-Q. Customer concentration persists as a key risk.
10-Q
Q1 FY2025 results
ADM Tronics swung to an operating profit of $164K in Q1 FY2025 ended June 30, 2024, up from a $138K loss a year earlier, while revenue climbed 12% y/y to $858K on stronger electronics sales of $411K despite softer engineering demand. Gross margins expanded to 61% from 43%, fueled by a 10% price hike and lower costs, yet operating expenses dropped 23% y/y to $357K, trimming SG&A bloat. A $113K gain from investment flipped the quarter profitable at $272K net, reconciling to $0.00 diluted EPS on 67.6M shares with 200K anti-dilutive warrants excluded. Cash dipped to $469K amid $59K operating outflow, supported by a $382K line of credit draw at 8.87% maturing May 2025 and $5K PPP remainder; free cash flow not disclosed in the 10-Q. No M&A or impairments noted. Customer concentration persists, with three buyers at 78% of receivables.
AEMD
Aethlon Medical, Inc.
5.75+0.32
AHCO
AdaptHealth Corp.
9.17-0.30
AMIX
Autonomix Medical, Inc.
1.05-0.04
DYNT
Dynatronics Corp.
0.05+0.00
INMD
InMode Ltd.
14.92-0.35
MDT
Medtronic plc.
91.73-1.50
NMTC
NeuroOne Medical Technologies C
0.79-0.03
NSYS
Nortech Systems Incorporated
9.59-0.04
NXL
Nexalin Technology, Inc.
1.55+0.07
SENS
Senseonics Holdings, Inc.
7.25+0.05